ExpreS2ion appoints new Chief Medical Officer
Hørsholm, Denmark, December 21, 2021 – ExpreS2ion Biotech Holding AB (“ExpreS2ion” or the “Company”) hereby announces the appointment of Dr. Mattis F. Ranthe as the Company’s new Chief Medical Officer (CMO). Dr. Ranthe brings a decade of broad clinical experience, and he will be responsible for ensuring the progression of ExpreS2ion’s development pipeline activities, including clinical safety and efficacy trials. Dr. Ranthe will begin his employment on February 1, 2022 at ExpreS2ion’s headquarters in Hørsholm, Denmark.Dr. Mattis F. Ranthe will take over the responsibility for the Company’s